Jennifer C. Goodell

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Opportunities for using in silico‐based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors”.

Opportunities for using in silico‐based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors

British Journal of Clinical Pharmacology(2020)10.1111/bcp.14369

N/A

0DataRank · unranked

35 citations

Daniel A. Goldstein, Jennifer C. Goodell, Ryan Nguyen, William D. Figg, Mark J. Ratain +1 more

Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation

The Journal of Clinical Pharmacology(2021)10.1002/jcph.1984

N/A

0DataRank · unranked

35 citations

Brian L. Heiss, Daniel A. Goldstein, Jennifer C. Goodell, William D. Figg, Mark J. Ratain +1 more

Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma

Journal of Chromatography B(2021)10.1016/j.jchromb.2021.122641

N/A

0DataRank · unranked

34 citations

Jennifer C. Goodell, Priya Shankarappa, Sara Zimmerman, Tyler Yin, Cody J. Peer +2 more

Quantitation of the next-generation imipridone ONC206 in human plasma by a simple and sensitive UPLC-MS/MS assay for clinical pharmacokinetic application

Journal of Pharmaceutical and Biomedical Analysis(2022)10.1016/j.jpba.2022.114685

N/A

0DataRank · unranked

7 citations

Sara Zimmerman, Cody J. Peer, Varun V. Prabhu, Tyler Yin, William J. Richardson +7 more